What is IDEAYA Biosciences, Inc.'s investing cash flow?

IDEAYA Biosciences, Inc. (IDYA) reported investing cash flow of $118.95M in Q1 2026.

How has IDEAYA Biosciences, Inc.'s investing cash flow changed year-over-year?

IDEAYA Biosciences, Inc.'s investing cash flow increased by 49.0% year-over-year, from $79.82M to $118.95M.

What does investing cash flow mean?

Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.

IDEAYA Biosciences, Inc. IDYA Investing Cash Flow

Investing Cash Flow at other companies

Bristol-Myers SquibbBMY

-$131M+73.7%

AmgenAMGN

-$716M-60.2%

Tango TherapeuticsTNGX

$9.64M-68.5%

Arcus BiosciencesRCUS

$114M+256%

Erasca, Inc.ERAS

-$243.83M-812%

ImmunomeIMNM

-$12.02M-336%

Other financials

Income statement

See full

Revenue$6.6M—

Operating income-$108.5M-28.6%

Net income-$98.5M-36.5%

EPS (diluted)-$1.11-35.4%

Balance sheet

See full

Cash & equivalents$157.5M+21.2%

Total debt$28.6M+10.1%

Total equity$937.3M-8.5%

Total assets$1.0B-6.4%

Cash flow

See full

Operating cash flow-$75.2M-24.6%

CapEx$967.0K-27.3%

Free cash flow-$76.1M-23.5%

Valuation

See full

Market cap$3.36B+104%

Enterprise value$3.23B+110%

P/S14.5×+9.9×

Profitability

See full

Operating margin-4,671.1%-5,434pp

Net margin-3,921.1%-4,562pp

FCF margin-3,592%-4,290pp

Returns & leverage

See full

Return on equity-14.3%-5.0pp

Debt / equity0×0.0×

Current ratio10.7×-3.2×

Where this comes from

Reported directly by IDEAYA Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.

The official record: IDEAYA Biosciences, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about IDEAYA Biosciences, Inc.'s investing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is IDEAYA Biosciences, Inc.'s investing cash flow?: IDEAYA Biosciences, Inc. (IDYA) reported investing cash flow of $118.95M in Q1 2026.
How has IDEAYA Biosciences, Inc.'s investing cash flow changed year-over-year?: IDEAYA Biosciences, Inc.'s investing cash flow increased by 49.0% year-over-year, from $79.82M to $118.95M.
What does investing cash flow mean?: Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.